Skip to content
Home/Companies/Biotech/Toleranzia

Toleranzia

Biotech·Sweden·Exited 2015·Held 4yr
Entry
2011
Hold
4yr
Exit
2015

Who owns Toleranzia?

Toleranzia is a Swedish Biotech company, formerly owned by GU Ventures, exited in 2015 (exit via IPO). No current private equity owner is on file.

Hand-verified · updated 2026-08-17

Open JSON · CC-BY
GU Ventures
Investor
GU Ventures
GU Ventures Evergreen · 1995 · VC

Key facts

HQSweden
SectorBiotech
StatusAcquired
Exit Type
IPO
Exit Year
2015

More from GU Ventures Evergreen

Other portfolio companies in the same fund.

Mucolife Therapeutics
Active
BiotechSweden· 2024
Pretzel Therapeutics
Pretzel Therapeutics
Active
BiotechUS· 2022
dpella
Active
Data & AnalyticsSweden· 2021
Nanolyze
Active
Deep TechSweden· 2020
SimSen Diagnostics
Active
MedTechSweden· 2020
Hydroc Energy Storage
Active
ClimateTechSweden· 2019

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS

Questions

Who owns Toleranzia?

Toleranzia was formerly owned by GU Ventures, exited in 2015. No current private equity owner is on file.

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue